Immuto Scientific's AI-assisted mass spec platform targets antibody-antigen structures at about 100 per week, where protein-folding models still misrank. Cryo-electron microscopy can deliver near-atomic and, in favorable cases, atomic-resolution protein structures, but sample preparation and grid optimization remain major bottlenecks. Immuto Scientific, co-founded in 2018 by CEO Faraz A. Choudhury, Ph.D. and CTO Daniel Benjamin, Ph.D., both electrical engineers by training, is making a narrower pitch: that for selected workflows, especially antibody-antigen analysis, its AI-assisted mass spectrometry platform can move much faster. “We can get data on about 1000 samples per week with our platform, so that roughly translates to…
Cryo-electron microscopy can deliver near-atomic and, in favorable cases, atomic-resolution protein structures, but sample preparation and grid optimization remain major bottlenecks. Immuto Scientific, co-founded in 2018 by CEO Faraz A. Choudhury, Ph.D. and CTO Daniel Benjamin, Ph.D., both electrical engineers by training, is making a narrower pitch: that for selected workflows, especially antibody-antigen analysis, its…
The post How Immuto Scientific pairs AI and mass spec for a step change in protein structure throughput appeared first on Drug Discovery and Development.
US Pharma Marketing